SK bioscience Co.,Ltd.
Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 302440.KS | 326030.KS | 261780.KQ | 085660.KQ | 095700.KQ | 6547.TWO | |
|---|---|---|---|---|---|---|
| Market cap | 2.90T | 7.10T | 103.62B | 677.77B | 94.14B | 15.63B |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | — | — | — | — | — | 32.6 |
| Price/book | — | — | — | — | — | 4.4 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −40.00% | −33.08% | +44.97% | −45.74% | −60.56% | +44.00% |
| Today | +7.10% | +12.27% | −2.90% | +5.96% | +0.73% | −2.16% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.
Latest news
All 302440.KS news ›SK Bioscience joins $99m BDBV vaccine development project
Business SK Bioscience joins $99m BDBV vaccine development project Published : Oct. 29, 2026 - 16:32:28 SK Bioscience said Thursday it will join a Bundibugyo virus vaccine development project backed by up to $99 million from the US…
SK Bioscience joins US-backed project to develop Bundibugyo Ebola vaccine
SK Bioscience’s Global R&PD Center in Songdo, Incheon / Courtesy of SK Bioscience SK Bioscience will join global partners in a U.S. government-funded project to develop and produce a vaccine against the Bundibugyo virus, a strain of Ebola…
SK bioscience Initiates International Phase 1/2 Clinical Trial of Universal Vaccine Candidate Targeting Sarbecovirus Family
29 Jan, 2026, 10:10 CST INCHEON, South Korea, Jan. 29, 2026 /PRNewswire/ -- SK bioscience announced the initiation of a global Phase 1/2 clinical trial in Australia for GBP511, a vaccine candidate targeting the sarbecovirus subgenus.…
SK bioscience Files for First-in-Human Trial of Universal Coronavirus Vaccine (Pan-sarbecovirus Vaccine) GBP511 Phase 1/2 study in Australia
Oct 15, 2025, 08:00 ET SEONGNAM, South Korea, Oct. 15, 2025 /PRNewswire/ -- SK bioscience announced that it has submitted a Phase 1/2 clinical trial application in Australia for GBP511, a universal coronavirus vaccine (pan-sarbecovirus…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- koreaherald.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.